The novel use of oral antibiotic monotherapy in prosthetic valve endocarditis caused by Finegoldia magna: a case study

Abstract Background Finegoldia magna, a Gram-positive anaerobic coccus, is part of the human normal microbiota as a commensal of mucocutaneous surfaces. However, it remains an uncommon pathogen in infective endocarditis, with only eight clinical cases previously reported in the literature. Currently...

Full description

Bibliographic Details
Main Authors: Siobhan Chien, David Gorman, Charilaos-Panagiotis Koutsogiannidis, Ramanish Ravishankar, Ganesh Kamath, Vipin Zamvar
Format: Article
Language:English
Published: BMC 2019-09-01
Series:Journal of Cardiothoracic Surgery
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13019-019-0993-9
_version_ 1818047337094709248
author Siobhan Chien
David Gorman
Charilaos-Panagiotis Koutsogiannidis
Ramanish Ravishankar
Ganesh Kamath
Vipin Zamvar
author_facet Siobhan Chien
David Gorman
Charilaos-Panagiotis Koutsogiannidis
Ramanish Ravishankar
Ganesh Kamath
Vipin Zamvar
author_sort Siobhan Chien
collection DOAJ
description Abstract Background Finegoldia magna, a Gram-positive anaerobic coccus, is part of the human normal microbiota as a commensal of mucocutaneous surfaces. However, it remains an uncommon pathogen in infective endocarditis, with only eight clinical cases previously reported in the literature. Currently, infective endocarditis is routinely treated with prolonged intravenous antibiotic therapy. However, recent research has found that switching patients to oral antibiotics is non-inferior to prolonged parenteral antibiotic treatment, challenging the current guidelines for the treatment of infective endocarditis. Case presentation This case report focuses on a 52-year-old gentleman, who presented with initially culture-negative infective endocarditis following bioprosthetic aortic valve replacement. Blood cultures later grew Finegoldia magna. Following initial intravenous antibiotic therapy and re-do surgical replacement of the prosthetic aortic valve, the patient was successfully switched to oral antibiotic monotherapy, an unusual strategy in the treatment of infective endocarditis inspired by the recent publication of the POET trial. He made excellent progress on an eight-week course of oral antibiotics and was successfully discharged from surgical follow-up. Conclusions This case is the 9th reported case of Finegoldia magna infective endocarditis in the literature. Our case also raises the possibility of a more patient-friendly and cost-effective means of providing long-term antibiotic therapy in suitable patients with prosthetic valve endocarditis and suggests that the principles highlighted in the POET trial can also be applicable to post-operative patients after cardiac surgery.
first_indexed 2024-12-10T10:04:11Z
format Article
id doaj.art-5251ea9403ff439dbfd6444a26c01851
institution Directory Open Access Journal
issn 1749-8090
language English
last_indexed 2024-12-10T10:04:11Z
publishDate 2019-09-01
publisher BMC
record_format Article
series Journal of Cardiothoracic Surgery
spelling doaj.art-5251ea9403ff439dbfd6444a26c018512022-12-22T01:53:17ZengBMCJournal of Cardiothoracic Surgery1749-80902019-09-011411510.1186/s13019-019-0993-9The novel use of oral antibiotic monotherapy in prosthetic valve endocarditis caused by Finegoldia magna: a case studySiobhan Chien0David Gorman1Charilaos-Panagiotis Koutsogiannidis2Ramanish Ravishankar3Ganesh Kamath4Vipin Zamvar5Department of Cardiothoracic Surgery, Royal Infirmary of EdinburghDepartment of Cardiothoracic Surgery, Royal Infirmary of EdinburghDepartment of Cardiothoracic Surgery, Royal Infirmary of EdinburghUniversity of EdinburghDepartment of Cardiothoracic Surgery, Kasturba Medical CollegeDepartment of Cardiothoracic Surgery, Royal Infirmary of EdinburghAbstract Background Finegoldia magna, a Gram-positive anaerobic coccus, is part of the human normal microbiota as a commensal of mucocutaneous surfaces. However, it remains an uncommon pathogen in infective endocarditis, with only eight clinical cases previously reported in the literature. Currently, infective endocarditis is routinely treated with prolonged intravenous antibiotic therapy. However, recent research has found that switching patients to oral antibiotics is non-inferior to prolonged parenteral antibiotic treatment, challenging the current guidelines for the treatment of infective endocarditis. Case presentation This case report focuses on a 52-year-old gentleman, who presented with initially culture-negative infective endocarditis following bioprosthetic aortic valve replacement. Blood cultures later grew Finegoldia magna. Following initial intravenous antibiotic therapy and re-do surgical replacement of the prosthetic aortic valve, the patient was successfully switched to oral antibiotic monotherapy, an unusual strategy in the treatment of infective endocarditis inspired by the recent publication of the POET trial. He made excellent progress on an eight-week course of oral antibiotics and was successfully discharged from surgical follow-up. Conclusions This case is the 9th reported case of Finegoldia magna infective endocarditis in the literature. Our case also raises the possibility of a more patient-friendly and cost-effective means of providing long-term antibiotic therapy in suitable patients with prosthetic valve endocarditis and suggests that the principles highlighted in the POET trial can also be applicable to post-operative patients after cardiac surgery.http://link.springer.com/article/10.1186/s13019-019-0993-9Finegoldia magnaProsthetic valve endocarditisOral antibioticsAdministrationCardiac surgical proceduresTreatment outcome
spellingShingle Siobhan Chien
David Gorman
Charilaos-Panagiotis Koutsogiannidis
Ramanish Ravishankar
Ganesh Kamath
Vipin Zamvar
The novel use of oral antibiotic monotherapy in prosthetic valve endocarditis caused by Finegoldia magna: a case study
Journal of Cardiothoracic Surgery
Finegoldia magna
Prosthetic valve endocarditis
Oral antibiotics
Administration
Cardiac surgical procedures
Treatment outcome
title The novel use of oral antibiotic monotherapy in prosthetic valve endocarditis caused by Finegoldia magna: a case study
title_full The novel use of oral antibiotic monotherapy in prosthetic valve endocarditis caused by Finegoldia magna: a case study
title_fullStr The novel use of oral antibiotic monotherapy in prosthetic valve endocarditis caused by Finegoldia magna: a case study
title_full_unstemmed The novel use of oral antibiotic monotherapy in prosthetic valve endocarditis caused by Finegoldia magna: a case study
title_short The novel use of oral antibiotic monotherapy in prosthetic valve endocarditis caused by Finegoldia magna: a case study
title_sort novel use of oral antibiotic monotherapy in prosthetic valve endocarditis caused by finegoldia magna a case study
topic Finegoldia magna
Prosthetic valve endocarditis
Oral antibiotics
Administration
Cardiac surgical procedures
Treatment outcome
url http://link.springer.com/article/10.1186/s13019-019-0993-9
work_keys_str_mv AT siobhanchien thenoveluseoforalantibioticmonotherapyinprostheticvalveendocarditiscausedbyfinegoldiamagnaacasestudy
AT davidgorman thenoveluseoforalantibioticmonotherapyinprostheticvalveendocarditiscausedbyfinegoldiamagnaacasestudy
AT charilaospanagiotiskoutsogiannidis thenoveluseoforalantibioticmonotherapyinprostheticvalveendocarditiscausedbyfinegoldiamagnaacasestudy
AT ramanishravishankar thenoveluseoforalantibioticmonotherapyinprostheticvalveendocarditiscausedbyfinegoldiamagnaacasestudy
AT ganeshkamath thenoveluseoforalantibioticmonotherapyinprostheticvalveendocarditiscausedbyfinegoldiamagnaacasestudy
AT vipinzamvar thenoveluseoforalantibioticmonotherapyinprostheticvalveendocarditiscausedbyfinegoldiamagnaacasestudy
AT siobhanchien noveluseoforalantibioticmonotherapyinprostheticvalveendocarditiscausedbyfinegoldiamagnaacasestudy
AT davidgorman noveluseoforalantibioticmonotherapyinprostheticvalveendocarditiscausedbyfinegoldiamagnaacasestudy
AT charilaospanagiotiskoutsogiannidis noveluseoforalantibioticmonotherapyinprostheticvalveendocarditiscausedbyfinegoldiamagnaacasestudy
AT ramanishravishankar noveluseoforalantibioticmonotherapyinprostheticvalveendocarditiscausedbyfinegoldiamagnaacasestudy
AT ganeshkamath noveluseoforalantibioticmonotherapyinprostheticvalveendocarditiscausedbyfinegoldiamagnaacasestudy
AT vipinzamvar noveluseoforalantibioticmonotherapyinprostheticvalveendocarditiscausedbyfinegoldiamagnaacasestudy